Mode
Text Size
Log in / Sign up

ST-Segment Elevation Myocardial Infarction

Part of Myocardial ischemia

11 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for ST-Segment Elevation Myocardial Infarction

5 trials tracked for ST-Segment Elevation Myocardial Infarction: 4 in phase 3 or 4 and 2 with published results. The most-cited published study has 152 citations.

5Trials tracked
4Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 4 Phase 2 1
  1. Phase 4 Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI Completed · 152 cited
  2. Phase 4 The Effect of IV Cangrelor and Oral Ticagrelor Study Completed · 46 cited
  3. Phase 4 Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction Completed
  4. Phase 4 Distal Protection Device in ST-elevation Myocardial Infarction (STEMI) Completed
  5. Phase 2 Sonothrombolysis in Patients With STEMI Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Myocardial ischemia

Related studies from across the Myocardial ischemia family.

Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
Drug Pipeline Guideline
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Current literature lacks research on myocardial infarction warning signs within transgender and gender diverse populations in the United States
Primary Care & Family Medicine Sys. Review
Current literature lacks research on myocardial infarction warning signs within transgender and gender diverse populations in the United States No clear guide exists for transgender heart attack warning signs in the United States
A brief review highlights a critical gap in understanding heart attack symptoms for transgender and gender diverse individuals. More researc…
A review found no current research on heart attack warning signs for transgender people, leaving them without standard heart health educatio…
Polygenic scores link to atherosclerosis and ischemic heart disease in Russian populations
Cardiology Meta-analysis
Polygenic scores link to atherosclerosis and ischemic heart disease in Russian populations Genetic markers help predict heart disease risk for Russian men and women
This meta-analysis review examines genetic predictors of atherosclerosis, ischemic heart disease, and myocardial infarction in a Russian pop…
A large study found specific genes linked to cholesterol levels in Russian people. These genetic scores can help doctors check heart disease…
Baduanjin exercise practice improves outcomes for patients with acute myocardial infarction undergoing percutaneous coronary intervention procedures
Cardiology Meta-analysis
Baduanjin exercise practice improves outcomes for patients with acute myocardial infarction undergoing percutaneous coronary intervention procedures Baduanjin exercise improves heart recovery and mood after heart attack surgery
A systematic review and meta-analysis of 1,293 patients with acute myocardial infarction undergoing percutaneous coronary intervention found…
A meta-analysis shows Baduanjin exercise improved heart function, walking distance, and mood in patients recovering from heart attacks and s…
Complete revascularization shows high probability of benefit for NSTEMI patients with multivessel disease
Cardiology RCT
Complete revascularization shows high probability of benefit for NSTEMI patients with multivessel disease Complete revascularization shows high probability of benefit for NSTEMI patients with multivessel disease
This Bayesian re-analysis of a randomized trial evaluated complete versus culprit-only revascularization in patients with non-ST-elevation m…
A Bayesian re-analysis suggests complete revascularization offers a high probability of clinically meaningful benefit compared to treating o…
Docetaxel chemotherapy is highly suspect for causing acute myocardial infarction in a low-risk triple-negative breast cancer patient
Cardiology Sys. Review
Docetaxel chemotherapy is highly suspect for causing acute myocardial infarction in a low-risk triple-negative breast cancer patient Docetaxel chemotherapy linked to rare heart attack in breast cancer patient
This case report and literature review examines acute myocardial infarction following docetaxel chemotherapy in a patient with triple-negati…
A rare heart attack occurred after docetaxel chemotherapy in a patient with triple-negative breast cancer. This case review suggests the dru…
Serum resistin levels rise progressively with worsening severity of coronary heart disease and acute myocardial infarction in this meta-analysis
Cardiology Meta-analysis
Serum resistin levels rise progressively with worsening severity of coronary heart disease and acute myocardial infarction in this meta-analysis High blood resistin levels linked to heart disease severity in large analysis
A network meta-analysis of 9,169 subjects reveals that serum resistin levels increase stepwise as coronary heart disease severity worsens. W…
A large network meta-analysis found that higher serum resistin levels are linked to worse coronary heart disease and acute heart attacks.
Review of immunomodulatory strategies for myocardial infarction notes major translational gaps and undefined heart-immune axis
Cardiology Sys. Review
Review of immunomodulatory strategies for myocardial infarction notes major translational gaps and undefined heart-immune axis New ideas for heart attack treatment face big scientific hurdles
This review examines immunomodulatory strategies targeting the CCR2/CCL2 axis, regulatory T cells, and macrophage polarization compared to c…
Experts review new immune-targeting strategies for heart attacks but note major gaps in understanding how the heart and immune system intera…
Breast arterial calcification linked to increased cardiovascular mortality risk
Radiology & Imaging Meta-analysis
Breast arterial calcification linked to increased cardiovascular mortality risk Calcified breast arteries linked to higher risk of heart disease and death
This meta-analysis examined associations between breast arterial calcification and cardiovascular outcomes. The authors observed that the pr…
A large analysis shows breast arterial calcification is associated with higher risks of heart failure, stroke, and death in women.
Network meta-analysis of oral Chinese patent medicines for myocardial infarction with heart failure
Cardiology Meta-analysis
Network meta-analysis of oral Chinese patent medicines for myocardial infarction with heart failure Four Chinese medicines show promise for heart failure after heart attack
This network meta-analysis evaluated oral Chinese patent medicines combined with conventional treatment in patients with myocardial infarcti…
A network meta-analysis of 42 trials found four oral Chinese patent medicines improved outcomes when added to standard heart failure treatme…
Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman
Ophthalmology Sys. Review
Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman Rare heart attack possible after fluorescein angiography in older adults with heart disease
This case report and review of the literature describes a 76-year-old woman with hypertension, hyperlipidemia, and type 2 diabetes mellitus …
A 76-year-old woman with heart disease had a heart attack shortly after a dye test, highlighting rare risks.
Meta-analysis shows no significant difference between immediate and staged revascularization for STEMI with multivessel disease
Cardiology Meta-analysis
Meta-analysis shows no significant difference between immediate and staged revascularization for STEMI with multivessel disease Immediate heart procedure shows no major benefit over staged approach for heart attack patients
This systematic review and meta-analysis evaluated patients with ST-elevation myocardial infarction and multivessel disease undergoing immed…
A large review of heart attack patients with multiple blocked arteries found that doing the full procedure right away did not lower the risk…

Questions about ST-Segment Elevation Myocardial Infarction

Are many current STEMI treatment guidelines based on strong scientific evidence?

No, many current STEMI treatment guidelines are based on moderate or low-quality evidence, with only a small fraction supported by high-level studies.

Full answer →
Can a CT scan show hidden lung water that predicts bad outcomes in STEMI?

Yes, a CT scan can detect hidden lung water (extravascular lung water) in STEMI patients, and this finding is linked to a higher risk of in-hospital major adverse cardiovascular events.

Full answer →
How accurate is the new model for predicting heart failure after STEMI surgery?

A new model predicts acute heart failure after STEMI PCI with 82.4% accuracy, 74% sensitivity, and 86.8% specificity, outperforming older scores.

Full answer →
Does the timing of my heart surgery affect how well blood flows in STEMI?

Yes, timing matters: longer delays from symptom onset to PCI are linked to worse blood flow and outcomes in STEMI.

Full answer →
Can taking nicorandil during heart surgery improve blood flow for STEMI patients?

Yes, a 2024 trial found that giving intracoronary nicorandil during primary PCI improves blood flow (TIMI grade) and reduces microvascular resistance in STEMI patients.

Full answer →
See all 5 questions about ST-Segment Elevation Myocardial Infarction →